You are here
FUNCTIONAL GENETICS, INC.
UEI: JVFQUDAK2JN5
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of Broad Spectrum Host Oriented Therapeutic Antibodies against Influe
Amount: $2,883,300.00DESCRIPTION (provided by applicant): Infection with influenza virus causes a highly contagious disease of the respiratory tract. Influenza represents a unique therapeutic challenge due to both seasona ...
SBIRPhase II2010Department of Health and Human Services National Institutes of Health -
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap
Amount: $2,793,520.00DESCRIPTION (provided by applicant): Human Immunodeficiency Virus (HIV-1) is a global threat to public health and poses an unprecedented challenge to drug development. HIV-1 drugs that directly target ...
SBIRPhase II2010Department of Health and Human Services National Institutes of Health -
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap
Amount: $299,370.00DESCRIPTION (provided by applicant): Human Immunodeficiency Virus (HIV-1) represents a global threat to public heath and an unprecedented challenge to drug development. Most HIV-1 drug development ha ...
SBIRPhase I2007Department of Health and Human Services National Institutes of Health -
Development of Therapeutic Agents Against Influenza by Targeting Host Factors
Amount: $992,687.00DESCRIPTION (provided by applicant): The traditional antiviral approach is to design drugs targeting viral proteins. It tends to have a relatively narrow spectrum of action and frequently need to be r ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health
